Control of VEGF-A transcriptional programs by pausing and genomic compartmentalization. by Kaikkonen, Minna U et al.
UC San Diego
UC San Diego Previously Published Works
Title
Control of VEGF-A transcriptional programs by pausing and genomic compartmentalization.
Permalink
https://escholarship.org/uc/item/5pp399gq
Journal
Nucleic acids research, 42(20)
ISSN
0305-1048
Authors
Kaikkonen, Minna U
Niskanen, Henri
Romanoski, Casey E
et al.
Publication Date
2014-11-01
DOI
10.1093/nar/gku1036
 
Peer reviewed
eScholarship.org Powered by the California Digital Library
University of California
12570–12584 Nucleic Acids Research, 2014, Vol. 42, No. 20 Published online 28 October 2014
doi: 10.1093/nar/gku1036
Control of VEGF-A transcriptional programs by
pausing and genomic compartmentalization
Minna U. Kaikkonen1,*, Henri Niskanen1, Casey E. Romanoski2, Emilia Kansanen1, Annukka
M. Kivela¨1, Jarkko Laitalainen1, Sven Heinz3, Christopher Benner3, Christopher K. Glass2,4
and Seppo Yla¨-Herttuala1,5
1A.I. Virtanen Institute for Molecular Sciences, Department of Biotechnology and Molecular Medicine, University of
Eastern Finland, PO Box 1627, 70211 Kuopio, Finland, 2Department of Cellular and Molecular Medicine, University
of California, San Diego, 9500 Gilman Drive, La Jolla, CA 92093-0651, USA, 3Salk Institute for Biological Studies,
10010 North Torrey Pines Road, La Jolla, CA 92037, USA, 4Department of Medicine, University of California, San
Diego, 9500 Gilman Drive, La Jolla, CA 92093-0651, USA and 5Science Service Center and Gene Therapy Unit,
Kuopio University Hospital, Finland
Received August 06, 2014; Revised October 09, 2014; Accepted October 11, 2014
ABSTRACT
Vascular endothelial growth factor A (VEGF-A) is
a master regulator of angiogenesis, vascular de-
velopment and function. In this study we inves-
tigated the transcriptional regulation of VEGF-A-
responsive genes in primary human aortic endothe-
lial cells (HAECs) and human umbilical vein endothe-
lial cells (HUVECs) using genome-wide global run-on
sequencing (GRO-Seq). We demonstrate that half of
VEGF-A-regulated gene promoters are characterized
by a transcriptionally competent paused RNA poly-
merase II (Pol II). We show that transition into produc-
tive elongation is a major mechanism of gene activa-
tion of virtually all VEGF-regulated genes, whereas
only ∼40% of the genes are induced at the level
of initiation. In addition, we report a comprehensive
chromatin interaction map generated in HUVECs us-
ing tethered conformation capture (TCC) and char-
acterize chromatin interactions in relation to tran-
scriptional activity. We demonstrate that sites of ac-
tive transcription are more likely to engage in chro-
matin looping and cell type-specific transcriptional
activity reflects the boundaries of chromatin interac-
tions. Furthermore, we identify large chromatin com-
partments with a tendency to be coordinately tran-
scribed upon VEGF-A stimulation. We provide evi-
dence that these compartments are enriched for clus-
ters of regulatory regions such as super-enhancers
and for disease-associated single nucleotide poly-
morphisms (SNPs). Collectively, these findings pro-
vide new insights into mechanisms behind VEGF-
A-regulated transcriptional programs in endothelial
cells.
INTRODUCTION
Angiogenesis, the formation of blood vessels during tissue
vascularization, involves a coordinated cascade of many
signaling processes. Vascular endothelial growth factor
(VEGF, VEGF-A) lies at the heart of this process, is es-
sential for endothelial cell function and angiogenesis dur-
ing development, and plays a major role in neovasculariza-
tion also later in life (1). On the other hand, pathological
angiogenesis is a hallmark of various ischemic and inflam-
matory diseases and cancer. Although the program of gene
expression regulated by VEGF has been widely studied, the
majority of genome-wide studies have focused on measur-
ing stable mRNA levels (2,3) and have resulted in a less de-
tailed understanding of the mechanisms affecting subsets of
critical genes. For example, many stimulus-responsive early
genes are regulated at the level of paused RNA polymerase
II (Pol II) accumulated approximately 50 bp downstream of
the transcription start site (reviewed in 4–6). This was first
shown for the Drosophila melanogaster hsp70 heat shock
gene, where gene induction in response to heat shock occurs
very rapidly (7,8). Since then, the prevalence of pausing has
been well established also in mammals, and according to
current knowledge, 30–40% of RefSeq genes exhibit signifi-
cant enrichment of promoter-proximal paused Pol II (4–6).
Coordinated responses to extra- and intracellular sig-
nals require the combined activity of promoters and en-
hancers, the latter containing the majority of binding sites
for transcription factors and thus being largely responsi-
ble for tissue-specific gene expression (9–11). This occurs
through the actions of a small number of key lineage-
determining transcription factors (LDTFs), which select
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enhancer regions in the genome and allow binding of signal-
dependent transcription factors (12,13). In endothelial cells,
the major transcriptional regulators include members of
the ETS, SOX, Forkhead (FOX), GATA and Kru¨ppel-like
families (KLF) (14). Especially the ETS family members,
including ETS1, ELF1, FLI1, TEL, and ERG, have well-
characterized roles in endothelial cell development and each
bind to the enhancers and activate the transcription of en-
dothelial genes. According to the current view, the selected
enhancers then regulate the target promoter via direct phys-
ical interaction (looping) and recruitment of transcriptional
coregulators, while participating in the establishment of
the spatial organization of the genome. Recent advances
in the development of chromosome conformation capture
(3C) methods (15) have advanced our understanding of the
topology of the mammalian genome. They have revealed
that compartments of transcriptionally active euchromatin
tend to group together separated from compartments of
inactive heterochromatin (16). The subcompartment-level
chromatin is further organized into megabase-scale topo-
logical domains which are already formed in embryonic
stem cells and remain relatively constant throughout devel-
opment (17). Notably, structural reorganization is seen dur-
ing cellular differentiation at a submegabase scale and these
lineage-specific subtopologies regulate establishment of cell
type-specific gene expression programs (18). These contacts
are reported to stay relatively stable to the effects of exter-
nal stimuli (19). The pre-existing chromatin landscape could
then be responsible for the selection and regulation of target
genes in a cell type-specific way.
The goal of this study was to elucidate the mecha-
nisms driving VEGF-regulated gene expression programs
at the level of initiation, elongation and chromatin orga-
nization using global-run on sequencing (GRO-Seq) and
tethered conformation capture (TCC) in primary human
endothelial cells. Our results demonstrate that half of the
VEGF-induced genes are poised for activation, character-
ized by high level of elongation competent Pol II, H3K4me3
and H3 acetylation. We also provide for the first time a
genome-wide chromatin interaction map of human um-
bilical vein endothelial cells (HUVECs) and demonstrate
how cell type-specific transcription could define the bound-
aries between active and inactive chromatin compartments.
Finally, we present evidence for compartmentalization of
VEGF-coregulated genes and show that these compart-
ments are enriched for clusters of regulatory regions and
disease-associated genes and DNA variation. The potential
implications of compartmental gene regulation in disease
are discussed.
MATERIALS AND METHODS
Cell culture
HUVECswere isolated from umbilical cords obtained from
the maternity ward of the Kuopio University Hospital by
the approval of the Kuopio University Hospital Ethics
Committee. HUVECs were maintained in endothelial cell
growthmedium (EGM; 0.1% human epidermal growth fac-
tor, 0.1% hydrocortisone, 0.1% Gentamicin-Amphotericin-
B, 0.4% bovine brain extract, 2% FBS; Lonza) on cell
culture flasks coated with 10 g/ml fibronectin (Sigma, St.
Louis, MO) and 0.05% gelatin in phosphate buffered saline
(PBS). HUVECs were used at passage 5. Human aortic en-
dothelial cells (HAECs) were purchased from Life Tech-
nologies, cultured as above and used at passage 8. For TCC,
the HUVECs were purchased from Life Technologies, cul-
tured as above and used at passage 8.
Treatments
Cells were seeded on 10 cm dishes and allowed to adhere for
24 h after which the cells were washedwithHank’s Balanced
Salt Solution and lipoprotein deficient medium (2% LPDS)
was added. After 16 h, cells were treated with 50 ng/ml
recombinant human VEGF-A165 (R&D Systems, Min-
neapolis,MN) for 2–8 h. siRNAknockdownwas performed
using Silencer R© Select siRNA against RAD21 and by com-
paring the gene expression to two control siRNAs #1 and
#2 (Life Technologies). Oligofectamine (Life Technologies)
was used to transduce the cells with a final concentration
of 5 nM of siRNAs. The gene expression and tube forma-
tion capacity was analyzed 48 h after siRNA treatment.
For the Matrigel assay, the cells were dry-trypsinized, sus-
pended intomedium containing 1%FBS and counted. Cells
were seeded onto growth factor reduced BD MatrigelTM
Basement Membrane Matrix and incubated for 16 h before
imaging with Olympus IX71 microscope.
GRO-Seq and RNA-Seq libraries
Global run-on and library preparation for sequencing was
performed as described in (20) with minor modifications.
Briefly, nuclei were extracted from 8 million cells grown
on two 10 cm plates and after run-on reaction the RNA
was extracted with Trizol LS Reagent (Life Technologies,
Carlsbad, CA, USA). RNA was treated with TURBO
DNase (Life Technologies), fragmented using RNA Frag-
mentation Reagents (Life Technologies) and purified by
running through P-30 column (Bio-Rad, Hercules, CA,
USA). The 3′ end of the fragmented RNA was dephos-
phorylated with T4 polynucleotide kinase (PNK; New
England Biolabs, Ipswich, MA, USA) followed by heat-
inactivation. Dephosphorylation reactions were purified
using anti-BrdU beads (SantaCruz Biotech, Santa Cruz,
CA, USA) and precipitated overnight. Poly(A)-tailing and
cDNA synthesis were performed the next day as described
(20). However, for reverse transcription an oligo allowing
custom barcoding during final amplification was used:
/5Phos/GATCGTCGGACTGTAGAACTCTGAAC/iSp
18/TCAGACGTGTGCTCTTCCGATCTTTTTTTTTTT
TTTTTTTTTVN (IDT). After cDNA synthesis, Exonu-
clease I (New England Biolabs) was used to catalyze the
removal of excess oligo. The DNA–RNA hybrid was pu-
rified using ChIP DNA Clean & Concentrator Kit (Zymo
Research Corporation, Irvine, CA, USA), RNaseH treated
and circularized. The libraries were amplified for 11–14
cycles with oNTI201-primer: 5′-AATGATACGGCGAC
CACCGACAGGTTCAGAGTTCTACAGTCCGACG-
3′ and a barcode specific primer oNTI200-index: 5′-
CAAGCAGAAGACGGCATACGAGATXXXXXXGT
GACTGGAGTTCAGACGTGTGCTCTTCCGATCT
(barcode XXXXXX underlined). The final product was
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ran on Novex 10% TBE gel, purified and cleaned up as
above.
For RNA-Seq libraries, RNA was purified using Trizol
and enriched for Poly(A)-RNA with MicroPoly(A) Purist
Kit (Life Technologies). Library cDNA was generated as
above but by replacing the bead purification step with gel
extraction on Novex 10% polyacrylamide TBE-urea gel
(Life Technologies). The libraries were sequenced on the Il-
lumina Genome Analyzer 2 or HiSeq 2000 according to the
manufacturer’s instructions.
ChIP-Seq libraries
ChIP-Seq libraries were prepared as previously described
(21). Briefly, formaldehyde (10′) fixed lysates were clarified
from sonicated nuclei and protein–DNA complexes were
isolated with H3K4me2 antibody (07-030; Millipore, Bil-
lerica, MA, USA). DNA was end-repaired using a combi-
nation of T4 DNA polymerase, Escherichia coli DNA Pol
I large fragment (Klenow polymerase; New England Bio-
labs) and PNK (Enzymatics Inc., Beverly, MA, USA). The
blunt, phosphorylated ends were treated with Klenow frag-
ment (minus exo; New England Biolabs) and dATP to yield
a protruding 3- ‘A’ base for ligation of Illumina’s adapters
that have a single ‘T’ base overhang at the 3′ end. After
adapter ligation, ChIPDNAwas polymerase chain reaction
(PCR) amplified with Illumina genomic adaptors or with
NEXTflex DNA barcode adaptors (Bioo Scientific Corpo-
ration, Austin, TX, USA) and library fragments were size-
selected (150–250 bp) from a 2% agarose gel. All libraries
were sequenced on Illumina HiSeq 2000 according to the
manufacturer’s instructions.
Tethered conformation capture
TCC was performed as described (22) with minor modi-
fications. Briefly, 90 million HUVECs were fixed with 1%
paraformaldehyde/PBS at room temperature for 10 min
and crosslinking was stopped by incubating cells 5 min in
the presence of 125 mM glycine. Cells were washed two
times with ice-cold PBS containing 0.5% bovine serum al-
bumin and scraped into lysis buffer containing 10 mMTris-
HCl (pH 7.4), 10 mM NaCl, 5 mM MgCl2, 0.2% NP-40
and protease inhibitor cocktail (Roche). Samples were vor-
texed, incubated on ice for 10 min, centrifugated for 5 min
in 1500 g in +4◦C and washed once again with lysis buffer.
Cells were washed twice with ice-cold wash buffer contain-
ing 50 mM Tris-HCl (pH 8.0), 50 mM NaCl and 0.5 M
ethylenediaminetetraacetic acid and nuclei were isolated by
incubating samples 10 min at +65◦C in wash buffer with
0.55% sodium dodecyl sulphate and collected by centrifu-
gation (1000 g for 1 min). Later steps followed the protocol
described (22), exceptMboI (NEB) was used to digest chro-
matin, T1 Streptavidin dynabeads (Life Technologies) were
used in all pulldown steps, NucleoSpin Gel & PCR Clean-
up kit (Macherey-Nagel) for clean-up steps and Biorup-
tor NextGen sonicator for DNA shearing (high setting, 30
s/30 s cycles for total 35 cycles). Libraries were amplified
in 15 PCR cycles and size-selected for 225–425 bp range
on 10% TBE gel (Life Technologies). Gel was grinded and
soaked with 0.1% Tween-20 and 150 mM NaCl and DNA
was eluted throughUltrafree centrifugal filter column (Mil-
lipore), cleaned up with ChIP DNA Clean & Concentrator
kit (Zymo Research) and paired-end sequenced with Illu-
mina HiSeq 2000.
RNA extraction and qPCR
RNA was extracted using the RNeasy Mini Kit (Qiagen),
TurboTM DNAse treated (Life Technologies) and converted
into cDNA using the SuperScript R© First-Strand Synthe-
sis System (Life Technologies). Quantitative PCR (qPCR)
was done to analyze the change in promoter-proximal Pol
II from the GRO-Seq prepared library and to monitor
the changes in mRNA levels upon VEGF stimulus from
the RNA extracted as above. qPCR was performed on an
Applied Biosystems StepOne PlusTM system using SYBR
GreenER mastermix (Invitrogen) and the following condi-
tions: 10 min at 50◦C and 10 min at 95◦C, followed by 40
cycles of 15 s at 95◦C, 15 s at 58◦C and 30 s at 70–72◦C.
Primer sequences are listed in Supplementary Table S4.
Data Analysis
Processing of sequencing data and analysis of differentially
regulated genes. GRO-Seq data was mapped using bowtie
and RNA-Seq using tophat allowing up to two mismatches
and reporting only one alignment for each read. Poor-
quality reads were filtered out (minimum 97% of bp over
quality cutoff 10). Each sequencing experiment was nor-
malized to a total of 107 uniquely mapped tags and visu-
alized by preparing custom tracks for the UCSC Genome
Browser. Differentially expressed genes were identified us-
ing edgeR (23) and thresholds of P-value < 0.05, RPKM
> 0.5 and fold change (FC) > 1.8 were used. Genes with
RPKM < 0.1 were considered ‘inactive.’ Micro RNAs and
small nucleolar RNAs were excluded from the analysis.
Clustering results were generated by Cluster 3.0 (24) by nor-
malizing gene expression tags to range from 0 to 1 and
performing average linkage clustering using the uncentered
Pearson correlation metric. The output from clustering was
viewed using Java Treeview (25). For gene ontology anal-
ysis, DAVID Bioinformatics Resources 6.7 (GOTERM BP
FAT; P-value < 0.01) (26,27) or HOMER (Biological Pro-
cess; P-value < 0.05) was used.
Pausing analysis. Sequencing data analysis (including
pausing analysis, peak finding, motif analysis and pro-
cessing and analysis of TCC data) was performed using
HOMER 4.3 and the detailed instructions for analysis can
be found at http://homer.salk.edu/homer (12) and below.
Pause ratio of genes was calculated as a ratio of RPKM
at the promoter (from transcriptional start site TSS to +200
bp) relative to the body of the gene (+200 bp to end of the
gene). Genes shorter than 400 bp were excluded from the
analysis. Gene was considered ‘paused’ if the pause ratio
was ≥ 3 and promoter RPKM ≥ 2. Pause ratio threshold
was selected based on plotting the pause ratios across ac-
tive genes (Supplementary Figure S1E). Promoter RPKM
≥ 2 was used to ensure significant level of expression within
the 200 bp to avoid false positives (i.e. ∼5 tags per sample
with the current sequencing depth). All the candidates were
further verified by visual inspection in UCSC Browser.
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To compare the Pol II ChIP-Seq signal to GRO-Seq at
the promoters (engaged to competent fraction of Pol II), the
tags at the body of the gene were used to normalize the sig-
nal at the promoter for each gene assuming that the amount
of Pol II is equal at gene bodies as described in (28). To
avoid false gene annotations, the TSS were redefined based
on GRO-Seq data using the ‘analyzeRNA.pl’ command in
the HOMER software with ‘-tss’ option. Only genes with
GRO- and Pol II ChIP-Seq RPKM > 0.5 at gene bodies
and > 2000 bp in size were used in the analysis.
ChIP-Seq peak finding and eRNA detection. Ge-
nomic binding regions enriched for H3K4me1/2/3
and H3K9/27ac were identified using the ‘findPeaks’
command in the HOMER software with default settings
for ‘style histone’ option: identification of 500 bp regions,
4-fold enrichment over input tag count 4, 0-fold enrichment
over local tag count and 0.001 false discovery rate (FDR)
significance. The settings for transcription factor peak
detection were those of ‘style factor’ option: identification
of 200 bp peaks, with 4-fold tag enrichment over input and
over local tags and 0.001 FDR significance. To analyze
if histone marks were enriched over the promoters of a
subgroup of genes, we analyzed the literal overlap of the
enriched regions as defined above with the 2 kb region
around the annotated ‘TSS’ of genes. To define intergenic
enhancers we selectively considered intergenic regions
defined as areas at least 3 kb away from the TSS of any
known RefSeq or UCSC gene to avoid false promoter
annotations. For analysis of intergenic eRNA expression,
also a region of 10 kb from the transcriptional termination
site (TTS) was excluded to avoid interference of coding
gene transcription downstream of the 3′ end of genes (29).
Motif analysis. Motif enrichment at promoters and regu-
latory regions was performed using the ‘findMotifs.pl’ and
‘findMotifsGenome.pl’ commands in the HOMER soft-
ware, respectively, with default settings: size used for mo-
tif finding was 200 bp and motif length 8, 10 and 12
bases. A random set of genomic positions matched for
GC% content was used as background. For motif analy-
sis at H3K4me2-defined enhancers, the signal was centered
around nucleosome-free regions (NFRs). This was done by
scanning each region, comparing the read density within
100 bp intervals relative to the flanking 150 bp regions and
assigning the NFR to a location with the greatest disparity
in read density.
Preprocessing of TCC data. For TCC analysis, reads from
paired-end sequencing were separately filtered and aligned
to the genome using bowtie. Each read was trimmed from
the 3′ end after GATC site and minimum read length was
set to 25 bp. Paired-end reads were connected and addi-
tional filtering steps were performed using HOMER 4.3.
Read pairs with exact same ends were only considered once
and read pairs were removed if they were separated by less
than 1.5× the estimated sequencing insert length to remove
likely continuous genomic fragments or re-ligation events.
Paired-end reads originating from regions of unusually high
tag density were left out by removing reads from 10 kb re-
gions that contain more than five times the average num-
ber of reads. Reads were filtered according to their distance
from a restriction site keeping only those read pairs that had
both of their reads aligning at most 1.5× fragment length
estimate from a restriction site. Reads were removed if their
ends form a self-ligation with adjacent restriction sites.
Analysis of individual interactions. Data normalization
and identification of significant interactions were done as
described in (30) using a resolution of 10 kb and P-value
< 0.001. FDR for significant interactions was estimated by
generating random experiment with the same sequencing
depth and by performing interaction search from this ran-
domized dataset, which gave an FDR estimate of <5%.
To associate interactions with nearby genes, study feature
enrichment at interaction endpoints and connect features
with interactions the HOMER command ‘annotateInterac-
tions.pl’ was used (30). The program uses positional over-
laps to assign interaction endpoints to ChIP-Seq peak loca-
tions and other genomic features. Gene targets are assigned
as the closest RefSeq annotated TSS relative to the inter-
action endpoint location. Feature enrichment is calculated
based on the expected overlap of features and interaction
endpoints given an effective genome size of 2×109 bp to
help correct for uninterrogable regions of the genome.
To assign an enhancer to a particular gene using TCC
data, the opposing end of each interaction originating from
an enhancer had to reside within 10 kb of the TSS. En-
richment of cis-regulatory elements with gene promoters
was calculated from the region 2–5 kb around TSS using
‘annotateInteractions.pl’ command. To study the HUVEC-
specific super-enhancers, we first identified the individual
H3K27ac regions that had been previously stitched together
to identify the clusters of enhancers called super-enhancers
(31). Subsequently, we studied the interactions originat-
ing from these H3K27ac regions compared to ‘normal’ en-
hancers that were located outside the boundaries of super-
enhancers. To investigate the enrichment of DNA sequence
variation or disease-associated genes within compartments,
we used the list of 15 328 single nucleotide polymorphisms
(SNPs) from NHGRI Catalog of Published Genome-Wide
Association Studies (GWAS) and 16 658 genes from Dis-
GeNET database (32,33). A list of cardiovascular disease
(CVD) associated genes was compiled by selecting diseases
linked to keywords cardiovascular, vascular, coronary and
cerebrovascular diseases.
Analysis of chromatin compartments and topological do-
mains. Principal component analysis (PCA) was per-
formed using the HOMER command ‘runHiCpca.pl.’
Briefly, this analysis divides the chromosomes into two sets
of loci (active/inactive) such that contacts within each set
are enriched and contacts between sets are depleted (16,30).
The HUVEC-specific active compartments were deter-
mined by comparing the PC1 values from IMR90/hESC
and HUVEC HiC data using 50 kb resolution. Regions of
continuous positive PC1 value were considered to be ac-
tive and differential compartments were analyzed by setting
the minimum difference between PC1 values to 80 (Supple-
mentary Figure S7A). The topological domains were iden-
tified using the HOMER command ’findHiCDomains.pl.’
This analysis is based on a statistic referred to as the ‘di-
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rectionality index,’ which describes the tendency of a given
position to interact with either the chromatin upstream or
downstream from its current position (17). A 50 kb window
was used for the analysis of chromatin compartments with
PCA (16,30), whereas 10 kb was used to detect topologi-
cal domains (17) (Supplementary Figure S5). To test for the
significant enrichment of super-enhancers/SNPs in chro-
matin compartments or regulated genes/disease-associated
genes we used the hypergeometric distribution function as
follows:
P(X = k) =
(
m
k
)(
N −m
n − k
)
(
N
n
) ,
where N is the total number of compartments or active
genes, m is the number of compartments containing reg-
ulated super-enhancers/SNPs or VEGF-regulated/disease-
associated genes, n is the number of VEGF-regulated com-
partments or active genes within VEGF-regulated com-
partments, and k is the number of compartments contain-
ing super-enhancers/SNPs or VEGF-regulated/disease-
associated genes within VEGF-regulated compartments.
As an additional control for compartment size, if the en-
richment within VEGF-regulated compartments was lower
than in three random sets of compartments of similar size
(total Mb), the enrichment was considered non-significant.
Statistical analysis and visualization of data
Statistical analyses were performed using Excel or Graph-
Pad Prism 5. The images were prepared using Excel, Graph-
Pad Prism 5, R package Geneplotter version 1.40.0, UCSC
Genome Browser and Photoshop CS5.1.
Data access
Experiments performed in this study are available in GEO
under the accession number GSE52642.
The public datasets analyzed can be found under ac-
cession numbers GSE41166 (H3K27ac, p300, ETS1 ChIP-
Seqs under VEGF treatment), GSE29611 (H3K4me2
[HUVEC and other ENCODE cell lines], H3K4me1/3,
H3K9ac, H3K27ac and Pol II ChIP-Seqs), GSE32465 (Pol
II ChIP-Seq), GSE31477 (cJUN, cFOS, GATA2 ChIP-
Seqs), GSE35156 (hESC and IMR90 HiC), GSE43070
(IMR90 GRO-Seq), GSE16256 (IMR90 H3K4me2 ChIP-
Seq) and GSE41009 (hESC GRO-Seq).
RESULTS
Transcriptional responses to VEGF-A
To investigate the effects of VEGF stimulation on early
transcription events, we quantified nascent transcripts fol-
lowing treatment of HUVEC and HAEC cells with recom-
binant human VEGF-A165 for 2 h (Supplementary Table
S1A). The short stimulation time allowed us to visualize
the leading edge of Pol II at long VEGF-responsive genes,
such as PDE4D and CHD13, and thus confirm the success
of GRO-Seq (Figure 1A). For these genes, we observed an
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Figure 1. Characterization of early transcriptional programs in re-
sponse to VEGF stimulus in primary endothelial cells. (A) UCSC
Genome Browser image for long VEGF-upregulated genes PDE4D
(chr5:58,245,963-59,070,890) and CHD13 (chr16:82,660,399-83,830,215)
in HAECs and HUVECs, respectively. Normalized tag counts for GRO-
Seq are shown under no treatment (Notx) and 2 h VEGF-A stimula-
tion. The red arrow indicates the trajectory that Pol II has traveled during
the stimulation. (B) Hierarchical clustering and heat map of the normal-
ized gene expression values for VEGF-regulated genes in HUVECs and
HAECs. Brackets to the right indicate major groups of genes.
elongation rate of ∼3 kb/min, which is in line with recent
reports (34,35). The biological replicates (each replicate of
pool of three donors) and HUVEC and HAEC cells had
high statistical correlation across gene bodies (Pearson cor-
relation r = 0.96; Supplementary Figure S1A).
GRO-Seq analysis identified 252 nascent RNA tran-
scripts regulated by more than 1.8-fold (reads per kilobase
per million reads, RPKM> 0.5, P-value< 0.05; Figure 1B,
Supplementary Figure S1B, Supplementary Table S1B) in
either cell population, which were highly enriched for bio-
logical pathways implicated in cell migration, blood vessel
development and regulation of cell proliferation (Supple-
mentary Table S1C). Hierarchical clustering revealed that
roughly half of these genes are commonly regulated in HU-
VECs and HAECs (Figure 1B), with ∼70% of the upregu-
lated genes and ∼40% of the downregulated genes showing
similar regulation (FC > 1.4). Overall, the biological repli-
cates and different endothelial cell lines were similar in their
response to VEGF stimulus (Supplementary Figure S1C).
To characterize how well GRO-Seq results correlate with
mature mRNA levels, we performed RNA-Seq in HUVECs
after 8 h treatment with recombinant VEGF-A 165. The
late time point was chosen to reflect the lag between tran-
scription and mature mRNA formation (29). Comparison
of differentially regulated genes detected by GRO-Seq or
RNA-Seq revealed correlation between the two methods
but also identified genes that were only classified as reg-
ulated by one of the sequencing methods (Supplementary
Figure S1D, Supplementary Table S1D). This suggested
that subgroups of genes are solely regulated at the transcrip-
tional or post-transcriptional level.
Half of VEGF-A-induced genes exhibit a paused phenotype
To study whether VEGF-regulated early genes are enriched
for a paused form of Pol II immediately downstream of
the TSS, we calculated the pause ratio for all the induced
genes in basal conditions by dividing promoter-proximal
tag counts by gene body tag counts (Figure 2A). Forty-six
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Figure 2. VEGF-regulated genes are controlled by the transition from
paused to elongating forms of Pol II. (A) The gene pause ratio (upper
figure) was defined as the ratio of strand-specific GRO-Seq tag density
(RPKM) within the proximal promoter (a = 0–200 bp) to the GRO-Seq
tag density at the gene body (b = +200 to end of the gene). Heat map of
the GRO-Seq tags (lower figure) at the promoter and at the body of the
gene sorted by the pause ratio. (B) Distribution of average GRO-Seq tag
densities on the + strand around the TSS of VEGF-upregulated genes dis-
playing paused or non-paused polymerase in basal conditions (no treat-
ment = Notx). (C) Gene ontology analysis of the paused (white) and non-
paused (black) VEGF-upregulated genes. Number of genes belonging to
the ontology group are indicated by red dots. UPR = unfolded protein
response. (D) Profile of GRO-Seq tag densities at the + strand of paused
genes where the induction was restricted to gene bodies. (E and F) UCSC
Genome Browser image depicting normalized GRO-Seq tag counts at (E)
HERPUD1 (chr16:56,965,000-56,985,000) andMEF2C (chr5:87,999,470-
88,188,000) genes upregulated at the level of elongation and (F) SLC12A
gene (chr5:127,418,000-127,554,000) upregulated at the level of elongation
and initiation. The lighter colors atMEF2CGRO-Seq signal indicate tran-
scription along the negative strand. (G) Fraction of VEGF-upregulated
genes displaying a paused (red) versus non-paused (blue) phenotype. All
genes are induced at the level of elongation but the fraction of genes also in-
duced at the level of initiation (FC> 2) are indicated with a checker board
pattern. (H) Histogram showing the distribution of engaged/competent
fraction for promoters of 500 top (black) and VEGF-upregulated (red)
paused genes. The dashed lines correspond to the median.
and sixty-one percents of the genes induced upon VEGF-
A stimulation in HUVECs and HAECs (HUVEC: 37/80
genes; HAEC: 92/151 genes) displayed a paused pheno-
type, respectively, thus exhibiting a pause ratio of over 3
(Figure 2A and B, Supplementary Figure S1E, Supplemen-
tary Table S1E). The pause ratios showed high similarity
between biological replicates (Supplementary Figure S1F).
Ontology (GO) analysis suggested that paused genes partic-
ipate in biological processes involved in signal transduction
pathways such as the unfolded protein response (UPR) and
signal transduction, whereas non-paused genes take part in
the regulation of cell motility and stress response suggest-
ing that they might be associated with different biological
processes (Figure 2C, Supplementary Table S1F).
To gain more detailed understanding of the transcrip-
tional stage at which the regulation occurs, whether it is
at the level of initiation or elongation, we next studied the
changes in GRO-Seq signal at the promoter and along the
gene body. Of the paused genes, 35–46% displayed an over
2-fold decrease in pause ratio upon VEGF-A stimulation
and were thus regulated mainly through release of Pol II
into productive elongation (17/37 HUVEC; 32/92 HAEC),
exemplified byHERPUD1 andMEF2C (Figure 2D and E).
In the case ofMEF2C, VEGF also stimulated the use of an
alternative promoter. Besides being induced at the level of
elongation, 34–47% of all VEGF-induced genes exhibited
over 2-fold increase at the level of promoter-proximal Pol
II (27/80 HUVEC, 71/151 HAEC; Supplementary Table
S1E, Figure 2G), illustrated by SLC12A2 (Figure 2B and
F). Similarly, all the VEGF-downregulated genes showed a
decrease in GRO-Seq at the gene bodies and 47–77% also
exhibited a significant decrease in the amount of promoter-
proximal Pol II inHAECs andHUVECs, respectively (Sup-
plementary Table S1E). This data confirms that VEGF-
regulated immediate-early genes are controlled by the tran-
sition from paused to elongating forms of Pol II.
GRO-seq only detects RNA polymerases engaged in
transcription and the increase in promoter-proximal GRO-
Seq signal at VEGF-induced genes could be either ex-
plained by (i) an increase in the initiation of transcription
with constant rate of elongation or (ii) an increase in the
fraction of Pol II that becomes elongation competent (i.e.
release of arrested form of Pol II (36)). To address this
question, we compared the GRO-Seq data to published Pol
II ChIP-Seq data from HUVECs (37). Pol II ChIP-Seq is
able to recognize both the elongation competent and in-
competent forms of Pol II and thus the ratio of two se-
quencing methods will reveal the fraction of engaged to
competent Pol II (28). Our analysis demonstrated that the
engaged/competent fraction at promoters of paused genes
fits a bell-shaped distribution, with a median close to 1 (log
2= 0) suggesting that the major form of Pol II is elongation
competent in basal conditions and the increase in promoter-
proximal GRO-Seq uponVEGF-stimulation is likely due to
increase in initiation (Figure 2H).
Several studies have demonstrated that active promoter
transcription is associated with positive chromatin marks
such as H3K4me3 and H3K9ac (38–40). To study if this
also holds true for VEGF-regulated genes, we analyzed
the pattern of H3K4me3, H3K9 and H3K27 using the
publicly available data (3,37). The H3K4me3 mark was
enriched over background at 100% of paused promoters
and 86% (38/44) of non-paused promoters, indicating that
this mark becomes established independently of the pro-
moter status. However, the level of H3K4me3 was sig-
nificantly higher at paused promoters (Figure 3A). Other
marks of active chromatin, namely acetylation ofH3K9 and
H3K27, were highly correlated with H3K4me3 and also
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Figure 3. VEGF-induced paused genes exhibit characteristics of actively
transcribed genes under basal conditions. (A andB) Box-and-whisker plots
of the ChIP-Seq tags around TSS (2 kb) of the paused and non-paused
genes. Boxes encompass the 25th to 75th percentile changes. Whiskers ex-
tend to 10th and 90th percentiles. The median tag count is indicated by
the central horizontal bar and the mean tag count fold by +. ***P-value<
0.001, **< 0.005, two-tailed Student’s test. (C) Temporal profile of change
in H3K27ac ChIP-Seq tags (3) around TSS of paused and non-paused
genes following VEGF treatment.
exhibited a significantly higher frequency at paused pro-
moters (Figure 3A). This suggested that acetyltransferases
such as p300 could be involved in setting up the acetyla-
tion at these sites. Indeed, analysis of p300 ChIP-Seq data in
VEGF-stimulated HUVECs indicated that p300 is present
at 66% (23/35) of paused promoters under basal condi-
tions compared to 34% (15/44) for non-paused ones (hy-
pergeometric test P-value: 0.005). The level of H3K27ac
and binding of p300 were proportionally increased upon
early VEGF stimulation at both paused and non-paused
promoters and returned to basal levels at later time points
(Figure 3B and C). This is in line with a recent report sug-
gesting that p300 is functionally involved in deposition of
H3K27ac in response to VEGF stimulation (3). Taken to-
gether, these data indicate that paused VEGF-responsive
genes in endothelial cells are characterized by the presence
of H3K4me3, H3K9ac and H3K27ac marks under basal
conditions, exhibiting histone modifications characteristic
of actively transcribed genes.
Regions of active transcription exhibit more chromatin inter-
actions
To analyze the role of enhancers in the regulation of VEGF-
transcriptional programwe usedH3K4me2ChIP-Seq to lo-
calize the regulatory regions in HUVEC and HAEC cells.
We identified ∼59 000 regulatory regions in HUVECs (37)
and ∼71 000 regions in HAECs. The subsequent analy-
sis was limited to ∼15 000 intergenic regions located at
least 3 kb away from the TSS and 10 kB from the TTS
of any known RefSeq or UCSC gene. In HUVECs, ∼90%
of these regions exhibited higher enrichment of H3K4me2
and H3K4me1 over H3K4me3 suggesting that the vast ma-
jority of regulatory regions used in the analysis are indeed
enhancers although we cannot exclude the presence of a
small fraction of promoters belonging to previously unan-
notated genes (Supplementary Figure S2A). Comparison
of the HUVEC and HAEC enhancers demonstrated that
60% were shared by both cell types. Moreover, ∼35% of
these regions showed no overlap with publicly available EN-
CODE data from HepG2, hESC1, HeLa, A549, IMR90
andMCF7 cells (37), indicating thatmany of these endothe-
lial enhancers are cell type specific (Supplementary Figure
S2B). Endothelial enhancers were highly enriched for mo-
tifs recognized by AP-1, ETS, IRF, SOX and FOX tran-
scription factors, consistent with previous findings (3,41),
further supporting the similarity of vein and artery en-
dothelial cells (Figure 4A).
As the common practice to link distal enhancers to their
nearest promoters can lead to false assignments, we wanted
to improve the target gene prediction by generating a map
of chromatin interactions in HUVECs using TCC (22).
We produced a total of 120 million paired-end reads and
computed interactions between loci with a window of 10
kilobases. From the filtered interaction data, we generated
genome-wide interaction matrices for each chromosome
(Figure 4B, Supplementary Figure S3). This analysis identi-
fied clusters of interacting genomic elements across the en-
tire length of chromosomes in HUVECs. In addition, we
identified a total of 87 240 significant interactions in HU-
VEC cells with a median distance of 168 kb (FDR < 5%;
Supplementary Table S2). Majority of the interactions were
between inter- or intragenic regions (75%), less than half
(42%) of whichwere enriched for histonemarks characteris-
tic of enhancers. Only 3% of interactions were between pro-
moters, whereas promoter-proximal elements represented
20% of interactions. Altogether, 241 interactions were as-
sociated with VEGF-regulated promoters and 25% of them
(61/241) were within enhancer regions. On the other hand,
a total of 538 interactions were associated with enhancers
exhibiting over 2-fold change in eRNA expression upon
VEGF stimulation. We next interrogated the expression of
genes looping to these enhancers compared to regions ex-
hibiting constitutive expression of eRNAs (Figure 4C, Sup-
plementary Table S3A). Our data demonstrated that eRNA
expression correlated well with changes in transcription of
the interacting gene (Figure 4D). No differences were seen
in the basal chromatin interactions between induced and re-
pressed enhancers suggesting that pre-existing interactions
do not determine the direction of regulation, i.e. up- or
downregulation (data not shown).
We next evaluated whether chromatin interactions could
explain promoter-proximal pausing. We observed no asso-
ciation between the two as active genes, whether paused
(43% of RefSeq) or non-paused, exhibited similar level
of interactions with the surrounding regions (Figure 4E).
However, significantly more interactions were seen at these
active genes compared to inactive ones (RPKM < 0.1). In
line with this, interaction endpoints associated with active
gene promoters exhibited significant enrichment of the ac-
tive histone marks H3K4me1/2/3 and H3K27ac whereas
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Figure 4. Characterization of endothelial enhancers and relationship between transcriptional activity and chromatin interactions. (A)De novomotif anal-
ysis of regulatory regions in HUVEC andHAEC cells. Motifs were identified by comparing the intergenic H3K4me2 regions to randomly selected genomic
regions. (B) Genome-wide contact matrix showing normalized intrachromosomal interactions involving chromosome 6 (Chr 6) at 200 kb resolution. Col-
ors indicate the ratio of observed interaction frequency to expected interaction frequency derived from background model (normalized for sequencing
coverage and distance between loci): blue, lower than expected; red, higher than expected. The centromere positions, devoid of any signal, are indicated
by red arrows. (C) Heat maps of normalized tag densities for GRO-Seq around 2 kb of intergenic H3K4me2 enhancers with significant eRNA expression
(RPKM > 0.5) centered to nucleosome-free regions. (D) Box-and-whisker plots of the fold change in expression of genes interacting with enhancers asso-
ciated with induced and repressed constitutive eRNA expression in HUVECs. Boxes encompass the 25th to 75th percentile changes. The median tag count
is indicated by the central horizontal bar and the mean tag count fold by +. *P-value < 0.05, ** < 0.005, one-tailed t-test compared to the constitutive
group. (E) Profiles of TCC interaction frequency centered on promoters comparing active (RPKM > 0.5) paused and non-paused and inactive genes
(RPKM < 0.1) identified using GRO-seq data. (F) Profiles of TCC contact frequency centered on enhancers, comparing regions with no or significant
eRNA expression. (G) Fold change in the promoter-proximal Pol II upon cohesin knockdown (blue bars) analyzed by qPCR from GRO-Seq libraries.
Effect of cohesin knockdown on mRNA expression analyzed from total RNA 8 h after VEGF treatment (red bars). The experiments represent results
from 2–4 replicates. (H) Effect of RAD21 knockdown on tube formation. HUVECs were seeded on growth factor reduced Matrigel after 48 h of siRNA
treatment and incubated for 16 h before imaging.
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these marks were depleted from inactive gene promoters
(Supplementary Figure S2C). Division of genes into quar-
tiles based on gene RPKM levels revealed that the interac-
tions are more prominent at highly expressed genes suggest-
ing that looping correlates more with the overall expression
level of a gene than with the pausing status (Supplementary
Figure S2D). Similarly active enhancers, producing eRNAs,
were more likely to interact with adjacent regions compared
to inactive regions (Figure 4F) suggesting and important
role for active transcription in establishing chromatin loops.
Growing evidence suggests an intimate link between tran-
scriptional pausing and enhancer function (42–44). It has
been demonstrated that stalled promoters promote higher
order chromatin organization, i.e. looping between pro-
moters and enhancers, but also that enhancers participate
in the regulation of transcriptional pause (43,44) release.
Cohesin has been shown to play a pivotal role in mediat-
ing specific long-range interactions within chromatin com-
partments and facilitate enhancer–promoter looping (45).
Moreover, cohesin depletion increases transcriptional paus-
ing in Drosophila cells (46). To probe the requirement of
cohesin in promoter-proximal pausing of VEGF-regulated
genes, we knocked down the RAD21, a subunit of co-
hesin in HUVECs. Knockdown efficiencies of ∼90% of
the mRNA were achieved (data not shown). The results
show that knockdown of RAD21 increased the level of
promoter-proximal Pol II at 5/7 of genes and reduced
the VEGF-mediated induction of mRNA expression (Fig-
ure 4G). Moreover, RAD21-specific siRNAmarkedly abol-
ishedHUVEC tube formation onMatrigel (Figure 4H). Al-
together, our results suggest that although paused and non-
paused genes exhibit similar level of interactions, the loop-
ing connections, in part mediated by cohesin, are crucial for
the regulation of the level of promoter-proximal pausing of
VEGF-regulated genes and angiogenesis.
VEGF-regulated genes localize to compartments with simi-
larly regulated genes
Recent studies have shown that interphase chromatin is par-
titioned into spatially segregated megabase-sized compart-
ments and submegabase-sized topological domains (16,17).
To analyze the organization of VEGF-regulated genes
within compartments, we partitioned each chromosome
into active, gene- and enhancer-rich, and inactive, gene-
poor, compartments using PCA (Figure 5A, Supplemen-
tary Figure S4A) (16,22). The active compartments prefer-
entially interact with other active compartments through-
out the genome, whereas the inactive tend to interact to-
gether (Supplementary Figure S4A). We identified 2022
active compartments in HUVECs, and the 108 VEGF-
regulated genes fell into 81 of them, with a median size of
1.65 Mb (Supplementary Table S3B). Average active gene
count (RPKM > 0.3) within the 81 compartments was 23
genes. To our surprise, many of the genes located in the
same compartment with VEGF-regulated genes exhibited
similar regulation irrespective of the paused or non-paused
phenotype (Figure 5A and B; data not shown). Notably, of
the 81 compartments, we could identify 16 compartments
of VEGF-upregulated and 9 compartments of downregu-
lated genes in which a significant fraction of genes were as-
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Figure 5. Identification of chromatin compartments enriched for VEGF-
regulated genes. (A) PC1 profile depicting active (black) and inactive (gray)
chromatin compartments in position chr5:50,000,000-68,500,000 (left).
Two-dimensional heat map surrounding the VEGF-upregulated chro-
matin compartment (highlighted red; chr5:53,150,001-59,150,000 at res-
olution of 10 kb) is shown on the right panel. Normalized tag counts
for GRO-Seq are shown for active genes (RPKM > 0.3) under no treat-
ment (Notx) and VEGF stimulation. Names of the upregulated genes are
highlighted in red and the topological domains are indicated by blue line
segments. (B) Scatter plot depicting average fold changes in gene expres-
sion upon VEGF stimulation in the 56 chromatin compartments con-
taining VEGF-upregulated gene(s) (UP) and 15 compartments associated
with downregulated gene(s) (DOWN). Chromatin compartments contain-
ing ≥3 genes are shown. (C) Scatter plot depicting fold changes in gene
expression upon VEGF stimulation in HUVECs. The genes included in
the upregulated (left) and downregulated (right) chromatin compartments
are shown. Red line denotes the mean fold change within compartment.
(D) Average fold change in gene expression in topologically associated do-
mains (TADs) along the VEGF-up- and downregulated compartments.
The order of compartments follows that of Figure 5C.
sociated with similar regulation (FC > 1.2; hypergeometric
test P-value< 0.05; Figure 5C, Supplementary Figure S4B,
Supplementary Table S3C).
Due to high similarity of HUVEC and HAEC cell
types, we next interrogated HAEC gene expression in
HUVEC-defined compartments. We saw a similar regula-
tion for 14/15 genes within the upregulated compartments
in HAECs (Supplementary Figure S4B, Supplementary Ta-
ble S3C). However, the correlation was poor within the
downregulated compartments where only 3/9 showed simi-
lar regulation, which is in line with the observation that only
40% of the repressed genes are shared by the two cell lines
(Figure 1B, Supplementary Figure S4B). This also implies
that downregulated compartments could exhibit more cell
type-specific regulation.
The active chromatin compartments can be further sub-
divided into smaller topologically associating domains
(TADs) that represent highly self-interacting regions sur-
rounded by segments that lack obvious chromatin inter-
actions (Figure 5A, Supplementary Figures S5 and S6A)
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(17,47). They are localized at active or inactive compart-
ments and have been shown to be highly tissue invariant.
We identified a total of 5717 topological domains in HU-
VECs at 10 kb resolution (Supplementary Figure S5) of
which 614 fell into the VEGF-regulated compartments sug-
gesting average division of VEGF compartments into ∼8
TADs (Figure 5A, Supplementary Figure S4A, Supplemen-
tary Table S3D). Previously, it was shown that expression
profiles of genes located within the same TAD are highly
correlated (47). To investigate if the VEGF-regulated genes
are located within a limited number of TADs within chro-
matin compartments, we focused our analysis on the 25
significantly VEGF-regulated compartments. These com-
partments comprised of 175 TADs of which 148 con-
tained active genes. We compared the average fold change
in gene expression within the 148 TADs and found that
similarly regulated genes within compartments were often
spread throughout the different topological domains (Fig-
ure 5A and D; Supplementary Table S3C). This suggests
that coordinately regulated TADs are integrated into larger
regulatory compartments potentially sharing common cis-
elements.
VEGF-regulated compartments are enriched for clusters of
regulatory regions bound by lineage-determining transcrip-
tion factors
To identify factors that might be responsible for select-
ing the compartments for VEGF-mediated regulation, we
further studied the regulatory elements located within the
compartments. The VEGF-regulated compartments were
enriched for the binding motifs of ETS1, AP-1, FOXP1
and NF1 at their regulatory regions (Figure 6A). To see
if the amount of ETS1 LDTF was higher in the VEGF-
regulated compartments, we took advantage of the public
ChIP-Seq data (3). To our surprise, we noticed that VEGF-
regulated compartments had significantlymore ETS1 peaks
than the non-regulated compartments either measured by
the number of peaks per compartment or RPKM (Fig-
ure 6B, Supplementary Figure S6). This correlated with
a higher number of H3K27ac regions in VEGF-regulated
compartments, suggesting that VEGF-regulated compart-
ments are enriched for clusters of regulatory regions (Figure
6B, Supplementary Figure S6).
Clusters of enhancers that are densely occupied by the
LDTFs andMediator, called super-enhancers, have been re-
cently identified as regulators of genes that define cell iden-
tity (48). Super-enhancers are found in a broad range of
human cells and they seem to play prominent roles in con-
trol of cell type-specific gene expression program (31). These
super-enhancers differ from typical enhancers in cell-type
specificity, size, transcription factor density and sensitivity
to perturbation such as depletion of LDTF orMediator. To
study if VEGF-regulated compartments could be regulated
by super-enhancers, we used the catalog of super-enhancers
created for various human cell types based on H3K27ac
ChIP-Seq data (31). To our surprise, significant fraction of
63% of VEGF-regulated compartments (51/81) coincided
with HUVEC-specific super-enhancers (31) compared to
23% of all compartments (461/2022) (hypergeom. test P
< 2E-15; Supplementary Table S3B). The super-enhancers
represented 12% (670/5369) of all the H3K27ac regions
within the VEGF-regulated compartments and were asso-
ciated with genes that were generally expressed at higher
levels than genes associated with typical enhancers (Figure
6C) (48). Interestingly, at the promoters that exhibit interac-
tions with super-enhancers, higher levels of transcriptional
induction and repression were observed than at the promot-
ers that interact with normal enhancers (Figure 6D).
As super-enhancers are densely occupied by master
regulators, we next investigated the role of endothe-
lial cell-specific lineage-determining factors ETS1, AP-1
(cJUN/cFOS) and GATA2 in defining the interactions
within VEGF-regulated chromatin compartments. Indeed,
we saw significant enrichment of ETS1, cFOS and GATA2
peaks at the interaction endpoints looping with promot-
ers of VEGF-regulated genes (Figure 6E). More detailed
analysis of the compartments enriched for up- or downreg-
ulated genes demonstrated that the upregulated gene pro-
moters exhibit more interactions with regions bound by
cJUN, cFOS and GATA2 compared to non-regulated gene
promoters or the genes within the downregulated compart-
ments (Figure 6E). Altogether this suggests that clusters of
enhancers, through the binding of endothelial specific tran-
scription factors, participate in the establishment of inter-
actions within VEGF-regulated chromatin compartments
and could thus be responsible for targeting specific chro-
matin compartments for regulation.
Recent studies suggest that much of disease-associated
DNA sequence variation occurs at enhancers and is fur-
ther enriched at super-enhancers (31,49). To investigate
whether DNA sequence variation or disease-associated
genes occur at VEGF-regulated compartments, we used
the list of 15 328 SNPs from NHGRI Catalog of Pub-
lished GWAS and 16 658 genes from DisGeNET database
(32,33). We found that VEGF-regulated compartments are
enriched for trait-associated SNPs (hypergeometric test P-
value = 2.5E-11) and especially SNPs linked to CVDs
(P-value = 1.2E-13; Figure 6F). The majority of trait-
associated SNPs were located at intergenic (33%) or in-
tronic regions (51%) and were further enriched in super-
enhancers compared to typical enhancers (hypergeometric
test P-value = 0.00004). Supporting the regulatory role of
these SNPs, VEGF-regulated compartments were also en-
riched for CVD-associated genes (P-value = 0.0016; Fig-
ure 6G). The enrichment for GWAS, SNPs and disease-
associated genes was also evident at the level of interactions
as interaction endpoints associated with VEGF regulated
compartments were more highly enriched for these features
compared to interactions associated with random com-
partments (GWAS SNPs: P-value 3.5E-05 versus 0.2; Dis-
GeNET genes: P-value 5E-72 versus 1.5E-15, respectively).
An example of such interaction is presented for the inflam-
matory CXCL8 gene, which is contacted by an enhancer
region containing disease-associated SNP (rs1371799) 370
kB downstream of the gene (Figure 6H). In line with in-
flammatory gene regulation, this SNP has been found to be
associated with white blood cell count in African Ameri-
can populations (50). Altogether, these results suggest that
altered expression of genes within VEGF-regulated chro-
matin compartments may contribute to disease.
12580 Nucleic Acids Research, 2014, Vol. 42, No. 20
Figure 6. VEGF-regulated compartments are enriched for clusters of enhancers. (A) Sequence motifs associated with the regulatory regions of chromatin
compartments containing VEGF-regulated genes when compared to randomly selected genomic loci. Regulatory regions were defined by a significant
enrichment of H3K4me1, H3K4me2 or H3K27ac. (B) Number of ETS1 peaks and H3K27ac regions associated with VEGF-regulated compartments or
non-regulated compartments. The average number per compartment is indicated in parentheses. (C) Box-and-whisker plots of the expression level (RPKM)
of genes interacting with super-enhancers (blue) or normal enhancers (orange) within VEGF-regulated chromatin compartments. Boxes encompass the
25th to 75th percentile changes. Whiskers extend to 10th and 90th percentiles. The median fold change is indicated by the central horizontal bar and the
mean by a red line. P-value based on one-tailed t-test is shown. (D) Box-and-whisker plots of the fold change in expression of genes interacting with super-
enhancers or normal enhancers within the VEGF-regulated chromatin compartments. Boxes encompass the 25th to 75th percentile changes and whiskers
extend to 10th and 90th percentiles. Themedian fold change is indicated by the central horizontal bar. For 81VEGF-regulated compartments, the geneswere
divided into upregulated (pink boxes 1–2; fold change> 1) and downregulated genes (green boxes 3–4; fold change< 1) whereas for 16 VEGF-upregulated
(pink boxes 5–6) and 9 VEGF-downregulated (green boxes 7–8) compartments all active genes are shown. P-values based on one-tailed t-test are indicated.
(E) Preferential interactions of VEGF-regulated gene promoters (2 kB aroundTSS)with endothelial-specific lineage-determining transcription factor peaks
based on ChIP-Seq data from (3,37). Heat map represents enrichment ratios, i.e. observed association frequency relative to expected frequency (association
strength; red) for each comparison exhibiting significantP-values< 0.005. Non-significant enrichment pairs are represented by gray boxes. Results from the
non-regulated genes are represented asmedian of four randomly selected sets of 108 non-regulated genes to allow comparison to 108VEGF-regulated genes.
(F and G) Overlap of SNPs and disease-associated genes in the NHGRI Catalog of Published GWAS and DisGeNET database (June 2014), respectively,
with HUVEC chromatin compartments. Average (F) SNP or (G) gene count is shown for all (2022), VEGF-regulated (81), VEGF-upregulated (16), and
VEGF-downregulated (9) compartments. *P-value < 0.007, ** < 0.0002, *** < 2.5E-11, hypergeometric test. (H) Significant interactions at CXCL-loci
(chr4:74,433,700-75,000,000). Regulatory regions defined by H3K27ac, gene annotations and the GWAS SNPs are shown. Of the SNPs, only rs1371799
is located within a HUVEC enhancer.
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Figure 7. Transcriptional activity reflects the boundaries of chromatin in-
teractions. (A) The PC1 values segregating chromatin into active (posi-
tive) and inactive (negative) compartments (50 kb resolution) are shown
for two representative regions exhibiting HUVEC-specific compartmental
boundaries compared to IMR90 (17). The differential regions are high-
lighted in pink. (B) Comparison of amount of GRO-Seq signal in HU-
VEC and IMR90 cells within HUVEC-specific compartments. (C) UCSC
GenomeBrowser image for theHOXA locus (chr7:27,130,000-27,241,000).
Normalized tag counts for GRO-Seq and H3K4me2-ChIP-Seq are shown
for HUVEC, HAEC and IMR90 cells. The location of CBS5-insulator in
IMR90 cells is indicated by an arrow. (D) Two-dimensional heat map sur-
rounding theHOXA locus in HUVECs. The PC1 values (50 kb resolution)
are shown together with normalized GRO-Seq tags above the heat map.
Ratio of observed interactions relative to expected interactions from back-
ground model (normalizing for sequencing coverage and distance between
loci) across chr7:26,600,000-27,401,000 at 10 kb resolution is shown. The
location of CBS5-insulator in IMR90 cells and potential insulator region
in HUVECs are indicated by an arrow. (E) Heat map of normalized GRO-
Seq tags for HOX-transcription factor genes showing differential gene ex-
pression between HUVEC and HAEC cells.
Transcriptional activity reflects the boundaries of chromatin
compartments
It has been shown that the chromatin compartments and
topological domains are highly similar between cell types
(16,17). Indeed, only ∼10% of HUVEC compartments
showed regions with significantly different boundaries com-
pared to compartments determined from the published
hESC1 or IMR90 HiC data (Figure 7A, Supplementary
Figure S7A, Supplementary Table S3E) (17). However,
to our surprise, 33% (27/81; hypergeom. test P > 0.002)
compartments containing VEGF-regulated genes and 81%
(13/16; hypergeom. test P > 1.5E-7) of compartments en-
riched for upregulated genes overlapped with HUVEC-
specific chromatin compartments suggesting an important
role for cell type-specific chromatin organization at these re-
gions.
We next sought to determine whether transcription it-
self could participate in defining the HUVEC-specific ac-
tive compartments. In support of this, the HUVEC-specific
chromatin compartments exhibited significantly more (P<
4E-89) GRO-Seq signal in HUVECs compared to IMR90
and hESC1 cells and vice versa (Figure 7B, Supplementary
Figure S7B and C). A striking example of transcription-
defined compartmental boundary was seen within the
VEGF-downregulated HOXA locus (Compartment #1,
Figure 7C and E). The HOXA locus was recently shown
to separate into two topological domains by an experimen-
tally validated CTCF binding site 5 (CBS5) insulator be-
tween HOXA7 and HOXA9 in IMR90 cells (17,51). Based
on previous GRO-Seq data from IMR90 cells, it was evi-
dent that the insulator also marks the end of transcription
(Figure 7C) (40). In contrast, we demonstrate that actively
transcribed regions extending fromHOXA1 toHOXA11 in
HUVECs interact with each other and with other active re-
gions. This active compartment is being followed by an inac-
tive compartment starting from HOX13 (Figure 7D). This
suggests that insulator elements within HOXA locus differ
in location between cell types. Accordingly, the absence of
transcription after HOXA5 gene, which was accompanied
by an absence in H3K4me2 mark, could indicate that the
location of insulator in HAECs is between HOXA5 and
HOXA6 genes (Figure 7C). Altogether, these data suggest
that the location of possible insulator regions in HOXA lo-
cus is dictated by active transcription in different cell types.
DISCUSSION
Growing evidence suggests that for a large number of hu-
man genes a major rate-limiting step in transcription is the
transition into productive elongation (4–6). These genes
are characterized by paused polymerases at their promot-
ers that are poised to respond to the positive transcrip-
tion elongation factor P-TEFb and enter into elongation
in response to appropriate signals (52,53). Our data sug-
gests that pausing is also a prevalent feature of genes in
endothelial cells. Similar proportion, i.e. 40–60%, of ac-
tive RefSeq genes and VEGF-regulated genes exhibited a
paused phenotype, suggesting that VEGF-regulated genes
do not form a distinct group of genes. This is in sharp
contrast to hypoxia-regulated genes that were previously
essentially all shown to be paused during normoxia (54).
Our data shows that release of the polymerase into pro-
ductive elongation is a major mechanism of gene activa-
tion and only roughly 40% of the VEGF-induced genes
are induced at the level of initiation. The paused VEGF-
induced promoters have distinct chromatin signatures char-
acterized by higher levels of H3K4me3, H3K9ac, H3K27ac
and binding of p300. These histone marks have been pre-
viously identified as the most important features for pre-
dicting the amount of Pol II at the promoter but their en-
richment does not seem to be sufficient for elongation (39).
Our data also demonstrates that cohesin, a central mediator
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of enhancer–promoter interactions, participates in the reg-
ulation of pausing. Cohesin depletion increased transcrip-
tional pausing in HUVECs similarly to what had been pre-
viously shown in Drosophila cells suggesting that cohesin
might facilitate the escape from the pause to productive
elongation (46). Identifying the cis-elements and factors re-
sponsible for Pol II escape into productive elongation will
be critical for understanding the VEGF-mediated regula-
tion of transcriptional programs and angiogenesis.
Previous studies have shown that TSSs preferentially in-
teract with active enhancer elements (30,55,56). Here, we
also show that transcriptionally active genes and enhancers
expressing eRNAs are more likely to engage in looping
interactions compared to regions devoid of transcription.
This is also supported by our observation that HUVEC-
specific chromatin compartments are more transcription-
ally active in comparison to fibroblasts. However, in the
light of current evidence, transcription might just be the
mere result of chromatin looping and not required for inter-
actions (19,56). Our data supports amodel in which binding
of LDTFs is responsible for establishing cell type-specific
chromatin compartments by establishing distinct transcrip-
tion signatures. Binding of LDTFs would then prime chro-
matin for recruitment of cohesin, mediator and coregula-
tors such as CTCF and p300 that participate in establishing
chromatin looping and fine-tuning the transcriptional out-
put such as pausing (46,57,58).
Coregulation of neighboring genes, or genes exhibiting
direct or indirect promoter–promoter interactions (genes
sharing common enhancers), has been widely described
in the literature (19,59,60). Recently, coordinately regu-
lated gene clusters, independent of the distance between
genes, were demonstrated to occur for promoters located
within the same topological domains at the mouse X-
inactivation center (47). Here, we identify large compart-
ments of VEGF-coregulated genes distributed across all
human chromosomes, where the similarly regulated genes
are distributed to multiple topological domains and are
thus distinct from previously described correlations. Eluci-
dation of the mechanism driving this compartmental regu-
lation will be the key to understanding the transcriptional
responses to proangiogenic stimuli. To this end, our analy-
sis provides strong support for the role of LDTFs in estab-
lishing the interactions needed for VEGF-regulated tran-
scriptional program in endothelial cells. First, the de novo
motif analysis of VEGF-regulated compartments shows
high enrichment of ETS1, AP-1 and FOXP1 transcription
factors. Secondly, we demonstrate that ETS1, AP-1 and
GATA2 are enriched at interaction pairs originating from
the VEGF-regulated promoters. This could also explain
why the HUVEC–specific chromatin compartments colo-
calize strongly with the compartments enriched for VEGF-
(up)regulated genes. Thirdly, our data demonstrates that
VEGF-regulated compartments are enriched for clusters of
regulatory regions, as evidenced by increased presence of
ETS1 binding sites and H3K27ac regions and enrichment
for super-enhancers. This suggests that coregulation seen
at compartments enriched for VEGF-regulated genes could
be due to colocalization of the genes to ‘transcription fac-
tories’ (60,61) or to bystander effects caused by transcrip-
tion factor recruitment to few highly regulated promoters
or enhancers. One can speculate that changes in the levels
or activity of transcription factors can have a more pro-
nounced ‘mass effect’ at clusters of enhancers compared
to common enhancers, explaining compartmental coregula-
tion. Supporting this view, high sensitivity to changes in the
level of transcription factors has been previously demon-
strated for super-enhancers (48). Nevertheless, further stud-
ies are needed to address whether regulation of clusters of
enhancers involve different rules of TF-DNA binding, such
as higher level of cooperativity, compared to common en-
hancers (62). We also found that disease-associated SNPs
occur at super-enhancers of VEGF-regulated compart-
ments, suggesting that altered expression of gene expression
within these compartments may contribute to diseases. The
enrichment was most evident for CVD-associated SNPs
and genes, providing evidence that angiogenesis could play
a role in the disease process. Indeed, angiogenesis has been
shown to contribute to atherosclerosis and other CVDs al-
though the causal relationships related to disease progres-
sion remain unclear (63). The identification of molecular
mechanisms underlying control of transcription and spatial
organization of VEGF-regulated chromosome compart-
ments could thus prove valuable for further understanding
of endothelial cell function and role in disease.
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